Charles McWherter, President of R&D at CymaBay Therapeutics, Inc. (CBAY), sold 43,486 shares at $14.07 ($612K) on 2023-10-18, disclosed to the SEC on 2023-10-18.
Open-market sale of $612k CBAY by President of R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.07 | 21,743 | $306K | 50.0% |
| 2 | $14.07 | 21,743 | $306K | 50.0% |
| Total | $14.07 avg | 43,486 | $612K | 100% |
| Filing → |
| CBAY | SELL | 2024-01-22 | $752K | — | Filing → |
| CBAY | SELL | 2023-12-18 | $487K | — | Filing → |
| CBAY | SELL | 2023-11-17 | $415K | — | Filing → |